30. ______. Prevenção e tratamento dos agravos resultantes da violência sexual contra mulheres e adolescentes.
Brasília, 2004.
31. CODE of Federal Regulations 45CFR 46. OPRR Reports: Protection of Human Subjects, 8 mar., 1983.
32. ORTIZ, M. A.; CROXATO, H. Mecanismos de acción de la anticoncepción de emergencia. Boletín CLAE, [s.l.],
v. 1, n. 2, p. 2, 2003.
33. PALOMINO, A. Efecto de levonorgestrel como anticoncepción de emergencia sobre receptores de endometrio
durante la ventana de implantación. Resúmenes de la XVIII reunión de la asociación latinoamericana de
investigadores en reproducción Humana, Cuba, p. 28-31, 2003.
34. PIAGGIO, G. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Lancet., [s.l.], v.
353, p. 721, 1999.
35. PYETT, P. M. Postcoital contraception: who uses the “morning after pill”? Aust N. Z. J. Obstet. Gynaecol., [s.l.],
v. 3, p. 347-350, 1996.
36. RADHAKRISHNA, A.; GRINGLE, R. E.; GREENSLADE, F. C. Identificando a interseção: adolescência, gravidez
não desejada, HIV/Aids e aborto em condições de risco. Chapel Hill, N. C.: Ipas, 1999.
37. RAMAN-WILMS, L. et al. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet.
Gynecol., [s.l.], v. 85, p. 141-149, 1995.
38. RAYMOND, E. et al. Effectiveness of meclizine in preventing nausea associated with emergency contraceptive
pills. Research Triangle N. C.: Family Health International, 1999.
39. RAYMOND, E. et al. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial
receptivity. Hum. Reprod., [s.l.], v. 15, p. 2351-2355, 2000.
40. ROWLANDS, S. et al. A possible mechanism of action of danazol and an ethinylestradiol/norgestrel
combination used as postcoital contraceptive agents. Contraception, [s.l.], v. 33, p. 539-545, 1986.
41. SCHIAVON, R. et al. Anticoncepción de emergencia: un método simple, seguro, efectivo y económico para
prevenir embarazos no deseados. Resúmenes de la Primera Conferencia del Consorcio Latinoamericano de
Anticoncepción de Emergencia, Quito, 2002.
42. SIMPSON, J. L.; PHILLIPS, O. P. Spermicides, hormonal contraception and congenital malformations. Adv.
Contracept., [s.l.], 1990, p. 141-167.
43. SOTO, G. M. Servicios amigables para jóvenes. Boletín CLAE, [s.l.], v. 1, n. 2, p. 9-10, 2003.
44. SWAHN, M. L. et al. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle.
Acta. Obstet. Gynecol. Scand., [s.l.], v. 75, p. 738-744, 1996.
45. TASK FORCE ON POSTOVULATORY METHODS OF FERTILITY REGULATION. Randomised controlled trial of
levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception.
Lancet., [s.l.], v. 352, p. 428-433, 1998.
46. TASKIN, O. et al. High doses of oral contraceptives do not alter endometrial ±1 and ± 3integrins in the late
implantation window. Fertil. Steril., [s.l.], v. 61, p. 850-855, 1994.
47. TORRES, J. H. R. Aspectos legais do abortamento. Jornal da Redesaúde, [s.l.], v. 18, p. 7-9, 1999.
48. TRUSSELL, J.; ELLERTSON, C.; STEWART, F. The effectiveness of the Yuzpe regimen of emergency contraception.
Fam. Plann. Perspect., [s.l.], v. 28, p. 58-64, 1996.
49. TRUSSELL, J.; RODRÍGUEZ, G.; ELLERTSON, C. New estimates of the effectiveness of the Yuzpe regimen of
emergency contraception. Contraception, [s.l.], n. 57, p. 363-369, 1998.
50. VAN LOOK , P. F. A.; STEWART, F. Emergency contraception. In HATCHER, R. A. et al. Contraceptive Technology.
17 ed. New York: Ardent Media, 1998.
51. VON HERTZEN, H. et al. Low dose mifeprostone and two regimes of levonorgestrel for emergency contraception:
a WHO multicentre randomized trial.
Lancet., [s.l.], v. 360, p. 1803-1810, 2002.
52. WEBB, A. Emergency contraception. Fert. Control. Rev., [s.l.], v. 4, p. 3-7, 1995.
53. ______. How safe is the Yuzpe method of emergency contraception. Fert. Control. Rev., [s.l.], v. 4, p. 16-18, 1995.
54. WILCOX, A. J.; WEINBERG, C. R.; BAIRD, D. D. Timing of sexual intercourse in relation to ovulation. Effects on
the probability of conception, survival of the pregnancy and sex of the baby. N. Engl. J. Med., [s.l.], v. 333, p.
1517-1521, 1995.
55.
_______. T
ime of implantation of the conceptus and loss of pr
egnancy
.
N. Engl. J. Med., v
. 340, p. 1796-99, 1999.
56.
WORLD HEALTH ORGANIZATION.
Improving access to quality care in family planning medical eligibility criteria
for initiating and continuing use of contraceptive methods. Geneva, 1996.
57. ______. Emergency contraception: a guide for service delivery: WHO/FRH7FPP798.19. Geneva, 1998.
58. ______. Safe abortion: technical and policy guidance for health systems. Geneva, 2003.
59. YUZPE, A.; PERCIVAL-SMITH, R.; RADEMAKER, A. W. A multicenter clinical investigation employing ethinyl
estradiol combined whith dl-norgestrel as a postcoital contraceptive agent. Fertility and Sterility, [s.l.], 1982.
20